News
CEO of Novo Nordisk, maker of weight loss drug Wegovy
Digest more
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...
The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post “for a period to support a smooth ...
Jørgensen has agreed to stay on while the search for a successor is carried out, and the chair of the Novo Nordisk Foundation ...
Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback